Maerua edulis
Maerua edulis · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Maerua edulis is a distinctive botanical species known for its significant potential in pharmacological research. Recent studies focusing on the n-hexane extracts of its root have revealed a diverse profile of bioactive secondary metabolites. Among the identified chemical constituents are (8Z)-14-methylhexadec-8-enal, methyl stearate, stigmasta-3,5-diene, and squalene. These specific compounds contribute to the plant's documented antiproliferative activities, which are of great interest in medicinal science. Understanding these chemical properties provides valuable insight into the therapeutic applications of this plant.
- Synonyms
- Physanthemum Glaucum · Maerua Camporum · 6 more
- Common names
- Not available
- Family
- Capparaceae
- Distribution
- Not available
- Plant Parts
- Root
Classification
Common Names
Maerua edulis is a versatile plant known by several distinct regional names. It is widely recognized by the common name Bush-Cherry in many areas. Depending on the local dialect, it is also referred to as Katunguru or Muswezu. Furthermore, the species is frequently identified as Soswe by those familiar with its growth. Finally, it holds the local name mutshalimela, reflecting its diverse cultural identity.
Sources: Catalogue of Life (COL)
Synonyms
Maerua edulis is a botanical species that has been documented under several different names throughout scientific history. It is closely associated with the genus Courbonia, appearing in various taxonomic records as Courbonia bussei and Courbonia calothamna. Researchers also recognize its synonymy with Courbonia camporum and Courbonia edulis in several studies. Additionally, the plant is frequently identified in literature as Courbonia glauca. These overlapping classifications highlight the complex nomenclatural relationships surrounding this particular species.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Maerua edulis is a distinct biological entity that belongs to the kingdom Plantae. Within this vast kingdom, the species is classified under the class Equisetopsida. It further fits into the specific order known as Brassicales. This plant is a member of the Capparaceae family, showcasing its unique evolutionary lineage. Ultimately, its botanical identity is defined by its placement within the genus Maerua.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Brassicales |
| Family | Capparaceae |
| Genus | Maerua |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Maerua edulis is a notable plant species widely distributed across various regions of the African continent. Within East Tropical Africa, its presence is firmly established in countries such as Kenya, Tanzania, and Uganda. The species also extends its reach into South Tropical Africa, flourishing in the landscapes of Malawi and Mozambique. This broad geographic range highlights the plant's ability to adapt to diverse ecological settings within these tropical zones. Consequently, understanding its distribution provides valuable insight into the botanical diversity of these interconnected African regions.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Maerua edulis is a distinctive self-supporting plant that typically adopts a shrub-like growth form. Depending on its specific environmental conditions, the species can vary significantly in its overall stature. While some individuals remain quite small with a minimum height of only 0.44 m, others may reach a maximum of 1 m. However, certain specimens are known to grow much larger, reaching heights of at least 2 m. This flexibility in size allows the plant to adapt effectively to its various habitats.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Maerua edulis has demonstrated significant antiproliferative activity, particularly when tested against human cervical cancer cell lines. Recent studies utilizing MTT assays and microscopic analyses have confirmed that root extracts from this plant can effectively suppress the proliferation of HeLa cells. Through GC-MS analysis, researchers identified key phytochemicals like squalene and methyl stearate that appear to drive these bioactive effects. The plant's mechanism of action likely involves the modulation of critical apoptosis and cell cycle-related genes, such as BCL2 and TP53. These findings suggest that Maerua edulis holds considerable therapeutic potential for the management of cervical cancer.
Compounds
Maerua edulis has long been utilized in traditional medicine to help manage various diseases, including cancer. Recent phytochemical investigations using GC-MS analysis have successfully identified several key bioactive compounds within its extracts. Notably, the research confirmed that Maerua edulis contains methyl stearate and squalene. These specific phytochemicals are believed to be closely associated with the plant's significant antiproliferative activity against cervical cancer cells. By potentially regulating apoptosis and cell cycle-related genes, these components highlight the plant's therapeutic promise in oncology.
Conditions
Maerua edulis n-hexane extracts demonstrate considerable antimycobacterial activity against both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Ra. These specific extracts showed minimum inhibitory concentrations ranging between 15.6 and 62.5 μg/mL during testing. The effectiveness of the plant against these mycobacterial species is attributed to its major components, which were identified as linear chain unsaturated fatty acids. Furthermore, the extracts of Maerua edulis exhibited moderate to no toxicity toward human macrophages. This profile suggests that the plant contains promising compounds for treating these specific mycobacterial strains.
Preparations
Maerua edulis is prepared as n-hexane extracts to facilitate its antimicrobial investigation. These specific extracts were subjected to sequential extraction processes alongside other solvents to identify active compounds. Research indicates that the n-hexane extract of this plant possesses considerable activity against Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Ra. Chemical analysis through (1)H NMR spectroscopy revealed that the major components within these n-hexane extracts are linear chain unsaturated fatty acids. This preparation method was essential for identifying the plant's potential as a source for anti-TB drug leads.
Parts used
Maerua edulis holds significant promise in the traditional management and treatment of various diseases, including cancer. Recent scientific investigations have specifically focused on the antiproliferative and cytotoxic effects of extracts derived from the root of this plant. Through rigorous testing on human cervical cancer cell lines, researchers identified that specific fractions of the root extract can significantly suppress cell proliferation. Detailed phytochemical analysis further revealed that compounds such as squalene and methyl stearate may drive these bioactivities by modulating key apoptosis and cell cycle-related genes. These findings suggest that Maerua edulis root extracts could serve as a potent therapeutic resource for the future management of cervical cancer.